Raising Health
Protecting the Golden Age of Medicine with John Crowley
Jul 23, 2024
John Crowley, President and CEO of BIO, shares his personal journey into biotech driven by his children's Pompe disease. They discuss navigating policies in medicine, developing treatments, rising costs of genetic medicines, and securing the medicine supply chain for national security.
30:33
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- John Crowley's relentless pursuit of developing a treatment for Pompe disease showcases his resilience and dedication in the face of adversity.
- Securing funding through unconventional means and strategic decisions propelled John Crowley's success in the biotechnology industry.
Deep dives
The Journey into Biotechnology Industry
John Crowley's entry into the biotechnology industry was sparked by his daughter's diagnosis with Pompe disease, a rare form of muscular dystrophy. Determined to find a treatment, he embarked on the path of researching and connecting with experts. Crowley's relentless pursuit led to the establishment of a company focused on developing a therapy for Pompe disease, showcasing his resilience and dedication in the face of adversity.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
